Attempts to characterize the biochemical defect or defects responsible for overproduction of uric acid in primary gout have been hampered by the lack of a suitable experimental model and the necessary limitations of research in vivo in man.
The purpose of the present study was to investigate metabolic abnormalities in purine metabolism in vitro using an intact human cell system. Leucocytes were chosen for study because of the ease with which they can be obtained and their relative resistance to non-physiological conditions (Fallon, Frei, Davidson, Trier, and Burk, 1962) .
The rate of incorporation of C-14 tagged purine precursors into nucleic acid adenine and guanine by isolated human leucocytes was measured in leucocytes obtained from hyperuricaemic subjects and normouricaemic controls. Increased incorporation of glycine C-14 by white cells from hyperuricaemic subjects was found.
Material and Methods
Uniformly labelled glycine-C-14 was used.** Phosphate buffer (Munroe and Shipp, 1965 ) pH 7*4 was prepared by diluting 10 ml. of Solution A (75 0 g. NaCl, 7*5 g. KCI, lO0 g. Na2HPO4, 1 * 7 g. KH2PO4, and 0 -5 g. K2HPO4 per litre) and 7 ml. of Solution B (10 0 g. NA2HPO4 per litre) to 100 ml. with water.
Pertinent clinical features of leucocyte donors are shown in Table I (see p. 277). All medications were discontinued 72 hours before blood was drawn. Subjects with blood urea nitrogen above 20 mg. per cent. or other evidence of impaired renal function were excluded. No patients with secondary hyperuricaemia were studied. All donors were ambulatory and not ill at the time blood was drawn. Uric acid was measured by the uricase method (Praetorius, 1949) . Normouricaemic donors had *Presented in part at the meeting of the American Rheumatism Association in Cincinnati, December, 1966. tUnited uric acid levels below 6 5 mg. per cent. Hyperuricaemic donors had uric acid levels above 7 mg. per cent. and a history of gouty arthritis. All but one subject in each group were adult males. Viability and metabolic activity of leucocytes isolated by dextran sedimentation techniques have been demonstrated (Fallon and others, 1962) . Viability was confirmed by their normal morphological appearance, motility, and staining characteristics with Trypan blue before and after incubation, and by the demonstration of linear incorporation rates of glycine-C-14 during4-hour incubations (Figure) Figure.
-Incorporation rates of glycine-C-14.
Separation of Leucocytes
All glassware was siliconized, rinsed, and freed of pyrogens. Leucocytes were separated from 50 ml. blood which had been drawn into a syringe pre-wetted with heparin. A technique similar to that of Munroe and Shipp (1965) 
Intracellular Glycine
Leucocytes were separated from 30 to 50 ml. of whole blood by collection in 5 per cent. sodium EDTA and lysis of the erythrocytes with dilute ammonium chloride (Di'oguardi, Agostoni, Fiorelli, and Lomanto, 1963) . The leucocrit was then estimated in a Wintrobe haematocrit tube, the leucocytes were taken up in distilled water, frozen and thawed several times to release the intracellular amino acids, and the suspension was chromatographed on a Technicon amino Autoanalyzer (Dickinson, Rosenblum, and Hamilton, 1965) . Intracellular glycine was expressed as micromoles of glycine per ml. packed leucocytes.
Results
The radioactive material isolated was identified by its identical migration with adenine and guanine in three different chromatographic solutions, isopropyl alcohol, hydrochloric acid and water (130: 33: 37), butanol and water (172 : 28), and water alone. Purity of the isolated material was assessed by counting duplicate aliquots after one-way chromatography and two-way chromatography using two of the above media. When mean glycine C-14 incorporation rates into adenine were 1,110 counts/min./3 x 107 cells using one-way chromatography, two-way chromatography resulted in 1,049 counts/min./3 x 107 cells. Corresponding data for guanine were 789 counts/min./3 x 1O7 cells with one-way chromatography and 741 counts/ min./3 x 107 cells with two-way chromatography.
The incorporation of glycine into adenine and guanine by white blood cells from fifteen normouricaemic adults and from fifteen adults with primary hyperuricaemia is shown in Table I incorporation rates of glycine observed could result levels (Table II) . A similar but less marked effect from differences in dilution of labelled glycine. occurred when oxidative metabolism was inhibited Essentially no difference in glycine pool size was by 3 x 107 molar cyanide. Incorporation of demonstrated in the two sets of white blood cells; the glycine into adenine decreased by 49 per cent. and mean glycine pool in cells from six control subjects into guanine by 48 per cent. (Table II) . Metabolic was 2-503 mM/ml. packed white blood cells com-inhibitors were equally effective on cells from normal pared with 2 * 663 mM/ml. packed white blood cells and hyperuricaemic subjects.
in the six hyperuricaemic subjects.
White blood cells from hyperuricaemic and norWhen anaerobic glycolysis was inhibited by mouricaemic donors were incubated with 5 mc. adding 104 molar iodacetamide to the incubation hypoxanthine-8-C-14 in a manner similar to that media, mean incorporation of glycine into adenine described for glycine. Hypoxanthine was converted decreased by 63 per cent. and mean incorporation to adenine and guanine and incorporated into into guanine decreased by 61 per cent. of control nucleic acids by the leucocytes from all 22 subjects group.bmj.com on April 14, 2017 -Published by http://ard.bmj.com/ Downloaded from studied. Mean rates of incorporation of hypoxanthine in white blood cells from ten normouricaemic subjects, expressed as counts/min./107 cells, were 18,052 for adenine and 11,132 for guanine. Analogous incorporation rates by white blood cells from twelve hyperuricaemic subjects were essentially the same; 22,062 for adenine and 11,201 for guanine (P >0 2). Similar incubations using 5 mc. xanthine-8-C-14 have shown no incorporation in the leucocytes of all subjects studied.
The ability of hypoxanthine to inhibit glycine-C-14 incorporation into nucleic acid was studied by incubating duplicate aliquots of leucocytes one of which contained 7 mg. per cent. non-radioactive hypoxanthine, with 1 mc. glycine-C-14 (Table II) . Mean rates of incorporation of glycine decreased by 16 per cent. for adenine and by 38 per cent. for guanine. This incorporation was inhibited equally in white blood cells from normouricaemic and gouty subjects.
Discussion
The linear increase in incorporation of glycine-C-14 (Figure) indicates that the leucocytes were metabolically active and incorporating this substrate into purine throughout the 4-hour incubation period. Further evidence of their functional integrity is provided by the presence of pseudopod formation, amoeboid movements, and phagocytic activity both before and after incubation.
The marked decrease in rate of incorporation of glycine seen when anaerobic glycolysis was inhibited by iodacetamide and oxidative metabolism by cyanide suggests that the system studied is energydependent and that an intact glycolytic pathway is required for optimal incorporation of glycine into purine.
The material isolated from the leucocytes was identified as adenine and guanine on the basis of absorbance in ultraviolet light, Rf values typical of adenine and guanine in three chromatographic solutions (Thomson, 1960) , and migration with added adenine and guanine in the same three solutions. The similar values for radioactivity obtained using one-way and two-way chromatography suggest that significant contaminating radioactivity was not present.
Although glycine C-14 was incorporated into adenine and guanine 1 * 8 times greater by leucocytes from hyperuricaemic than from normouricaemic subjects (Table I) , the large overlap between the two groups of data suggests either a relatively minor quantitative abnormality, or that the hyperuricaemic subjects represented a heterogeneous group, only a portion of whom have leucocytes which overincorporate glycine. Since 24-hour urinary uric acid excretions by the subjects were not measured, one cannot know whether the subjects whose leucocytes overincorporated in this study are renal overexcretors.
The nature of the abnormality responsible for the observed difference in incorporation rates of this purine precursor is unknown. Free purine base, soluble ribonucleic acid (RNA), and desoxyribonucleic acid (DNA) can be extracted separately with different concentrations of perchloric acid (Ogur and Rosen, 1950) . In the procedure used for the present study, acid-soluble RNA and any remaining free purine base are extracted in the 70 per cent. ethanol, ethanol-acetic acid, and 2 per cent. perchloric acid extractions (Feinendegen, Bond, and Painter, 1961) . Thus, the method used measures only the adenine and guanine incorporated into DNA and the insoluble fraction of cellular RNA. Overincorporation of glycine by white blood cells from hyperuricaemic subjects in this assay system cannot result from excessive activity of a shunt pathway, since the overincorporation is into purine bases isolated from nucleic acid (Benedict, Yu, Bien, Gutman, and Stetten, 1953) . Since the leucocyte glycine pool size was essentially the same in the normouricaemic and hyperuricaemic subjects, the differential incorporation rates of glycine observed cannot result from variations in the degree of dilution of isotopically-labelled glycine in the intracellular glycine pool.
Adenine and guanine are not metabolic endproducts of purine metabolism, and accordingly measuring their concentrations cannot give complete data on the state of purine metabolism. Glycine incorporation rates determined with the present technique do not necessarily reflect the overall rate of de novo purine biosynthesis. Abnormalities of purine metabolism involving pathways, such as the shunt pathway, which do not result in the incorporation of purine into insoluble RNA or DNA would not be detected.
The conversion of hypoxanthine-C-14 to adenine and guanine was expected, since at least two mechanisms for resynthesis of ribonucleotides from free purine bases including hypoxanthine are known to exist (Wyngaarden, 1966) . This conversion probably represents an important source of ribonucleotides in some tissues (Abrams and Bentley, 1955) . No difference was found in the rate of GLYCINE-C-14 INCORPORATION INTO NUCLEIC ACID PURINE incorporation of hypoxanthine by leucocytes from hyperuricaemic and normouricaemic subjects. This suggests that the site at which the hyperuricaemics studied overincorporate purine is prior to the point where hypoxanthine is recycled into the pathway. Partial deficiency of the enzyme hypoxanthineguanine phosphoribosyl transferase reported to be found in some adult gouty subjects (Kelley, Rosenbloom, Henderson, and Seegmiller, 1967) was not demonstrated in any of the gouty subjects studied. The failure to detect incorporation of xanthine-C-14 into nucleic acid indicates that, at least by this leucocyte assay system, human white blood cells lack a significant salvage pathway for xanthine.
Unlabelled hypoxanthine was added to the incubation media to study its effect on de novo purine biosynthesis. Feedback inhibition of de novo purine biosynthesis is thought to result from inhibition of glutamine phosphoribosylpyrophosphate amidotransferase by adenylic and guanylic acid (Wyngaarden and Ashton, 1959; Henderson, 1962; Caskey, Ashton, and Wyngaarden, 1964) . Hypoxanthine is probably converted to adenylic and guanylic acid in this system. The inhibition of glycine-C-14 incorporation produced by hypoxanthine in the leucocyte system probably results from increased cellular levels of these compounds. Inhibition was produced by hypoxanthine in the two gouty subjects studied, providing indirect evidence that feedback inhibition of de novo purine synthesis by adenylic and guanylic acid was not deranged in them. Such an abnormality has recently been described in some adult gouty subjects (Rosenbloom, Henderson, Kelley, and Seegmiller, 1968) .
The demonstration of an abnormality in purine metabolism in white blood cells from adults with primary hyperuricaemia makes available a system for the further evaluation in vitro of the metabolic derangements characteristic of gout. This system could provide a valuable experimental model for attempts to delineate in vitro the biochemical defect or defects responsible for overproduction of uric acid in gout.
Summary
The incorporation of carbon-14 tagged purine precursors into adenine and guanine of insoluble RNA and DNA of human white blood cells was measured in vitro. Leucocytes from hyperuricaemic subjects incorporated 80 per cent. more glycine-C-14 into nucleic acid adenine and guanine than did leucocytes from normouricaemic controls. Glycine-C-14 incorporation was inhibited by iodoacetamide, cyanide and hypoxanthine. Inhibition was equal in cells from hyperuricaemic and normouricaemic subjects. The potential value for future research of an in vitro system showing an abnormality of purine metabolism in hyperuricaemic subjects is emphasized.
L'incorporation de la glycine-C-14 a la purine de I'acide nucleique par les leucocytes obtenus de sujets sains et goutteux RESUME L'incorporation des precurseurs de la purine contenant du carbon-14 a l'adenine et a la guanine des acides insolubles ribo-nucleique et deoxyribose-nucleique des globules blancs de l'homme a 6te mesuree in vitro. Les leucocytes des sujets hyperuricemiques avaient incorpore 80 pour cent. plus de glycine-C-14 dans l'adenine et la guanine de l'acide nucleique que ne l'avaient fait les leucocytes des temoins a acide urique sanguin normal. L'incorporation de la glycine-C-14 etait inhib&e par l'iodoacemide, le cyanure et l'hypoxanthine. L'inhibition etait egale dans les cellules des sujets hyperuricemiques et celles des sujets a acide urique sanguin normal.
La valeur pour des recherches ult6rieures d'un systeme in vitro montrant une anomalie du metabolisme des purines chez des sujets hyperuricemiques est soulignee.
Incorporacion de glicina-C-14 en purina de acido nucleico por leucocitos obtenidos de sujetos normales y gotosos SUMARIO La incorporaci6n de precursores depurina, marcados por el carb6n-I4 en la adeninay la guanina del ARN y del ADN de gl6bulos blancos humanos fue medida in vitro. Los leucocitos de sujetos hiperuricemicos incorporaron 80 por ciento mas de glicina-C-14 en adenina y guanina de acido nucleico que los leucocitos de testigos normouric&-micos. La incorporacion de glicina-C-14 fue inhibida por yodoacetamida, cianuro e hipoxantina. La inhibici6n fue igual en celulas de sujetos hiperuricemicos y normouricemicos. Se subraya el posible valor, para investigaciones futuras, de un sistema in vitro que muestra una anormalidad del metabolismo de la purina en sujetos hiperuricemicos. 
